Adiposity
2
Pipeline Programs
4
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
2
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
4 companies ranked by most advanced pipeline stage
Human BioSciencesWV - Martinsburg
1 programMaternal Lipids and Offspring Adiposity at 5-7 YearsN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
AbbVieInjectable sodium deoxycholate
ErbeHybrid Argonplasma coagulation
Human BioSciencesMaternal Lipids and Offspring Adiposity at 5-7 Years
Clinical Trials (3)
Total enrollment: 1,267 patients across 3 trials
Kybella With Triamcinolone
Start: Mar 2018Est. completion: Dec 201830 patients
Phase 4Completed
Endoscopic Gastric Mucosal Ablation (GMA) of Class III Obesity
Start: Apr 2023Est. completion: Mar 202613 patients
N/AActive Not Recruiting
Maternal Lipids and Offspring Adiposity at 5-7 Years
Start: Jan 2001Est. completion: Mar 20121,224 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
4 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.